HIV prevention pill levels measured in kenyan women
NCT ID NCT05140954
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 26 times
Summary
This study looked at how safe and effective a daily HIV prevention pill (TAF-FTC) is in 54 Kenyan women at risk of HIV. Participants took different numbers of pills each week to see how drug levels build up in the blood. The goal is to help doctors better understand how well the pill works for women and improve HIV prevention programs.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kenya Medical Research Institute - Partners in Health Research and Development
Thika, Kenya
Conditions
Explore the condition pages connected to this study.